Sökning: "integrative oncology"

Visar resultat 1 - 5 av 13 avhandlingar innehållade orden integrative oncology.

  1. 1. Complementary and alternative medicine in cancer : from utilization to a randomized controlled trial

    Författare :Kathrin Wode; Per Fransson; Roger Henriksson; Lena Sharp; Johanna Hök Nordberg; Vinjar Magne Fønnebø; Umeå universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; oncology; epidemiology; evidence-based medicine; neoplasms; pancreatic neoplasms; adult; integrative oncology; complementary therapies; treatment refusal; communication; physician-patient relations; mistletoe; palliative care; quality of life; cross-sectional studies; qualitative research; randomized controlled trial; Sweden; Europe; medicin; Medicine;

    Sammanfattning : Background: Complementary and alternative medicine (CAM) are non-conventional health care approaches used in parallel with or instead of conventional medicine. Little is known about Swedish patients’ patterns of complementary CAM use in the context of cancer. LÄS MER

  3. 2. Regulation of Gene Expression in Multiple Myeloma Cells and Normal Fibroblasts : Integrative Bioinformatic and Experimental Approaches

    Författare :Prasoon Agarwal; Helena Jernberg Wiklund; Håkan Axelson; Uppsala universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; NATURVETENSKAP; NATURAL SCIENCES; NATURVETENSKAP; NATURAL SCIENCES; Multiple myeloma; Integrative bioinformatics; Epigenetics; CGGBP1; RNA polymerase; Oncology; Onkologi; Bioinformatik; Bioinformatics;

    Sammanfattning : The work presented in this thesis applies integrative genomic and experimental approaches to investigate mechanisms involved in regulation of gene expression in the context of disease and normal cell biology.In papers I and II, we have explored the role of epigenetic regulation of gene expression in multiple myeloma (MM). LÄS MER

  4. 3. Large scale integration and interactive exploration of cancer data – with applications to glioblastoma

    Författare :Patrik Johansson; Sven Nelander; Rebecka Jörnsten; Lene Uhrbom; Gary Bader; Uppsala universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; NATURVETENSKAP; NATURAL SCIENCES; Glioblastoma; data integration; network modeling; interactive exploration; precision medicine; Oncology; Onkologi; Molekylär medicin; Molecular Medicine; Statistics; Statistik;

    Sammanfattning : Glioblastoma is the most common malignant brain tumor, with a median survival of approximately 15 months. The standard of care treatment consists of surgical resection followed by radiotherapy and chemotherapy, where chemotherapy only prolongs survival by approximately 3 months. LÄS MER

  5. 4. Integrative genomic and survival analysis of breast tumors

    Författare :Szilard Nemes; Göteborgs universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; biostatistics; cancer; survival analysis; gemonics; DNA copy number aberrations; messenger RNA;

    Sammanfattning : With the continued accumulation of genomic data at ever increasing resolution the challenge ahead lies in reading out meaningful clinical/biological information form the data that can contribute to a better understanding of the cancerous process. The need for novel approaches, new statistical methods is therefore strong. LÄS MER

  7. 5. Novel biomarkers associated with histotype and clinical outcome in early-stage ovarian carcinoma

    Författare :Hanna Engqvist; Göteborgs universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; ovarian carcinoma; histotype-specific diagnosis and prognosis; molecular biomarker; outcome prediction; integrative analysis;

    Sammanfattning : Ovarian cancer is a collective name for multiple malignancies deriving from or involving the ovary, mainly comprising five histotypes of epithelial origin (clear-cell (CCC), endometrioid (EC), high-grade serous (HGSC), low-grade serous (LGSC), and mucinous carcinomas (MC)) with varying clinical (e.g. LÄS MER